Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. - Wikidata - awgldk - TriplyDB

Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.

Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.

http://www.wikidata.org/entity/Q38425522

about

Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries.Estrogen-Related Factors in the Frontal Lobe of Alzheimer's Disease Patients and Importance of Body Mass Index.Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1.Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.Insufficient antibody validation challenges oestrogen receptor beta research.Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer.Selective Estrogen Receptor Modulation by Larrea nitida on MCF-7 Cell Proliferation and Immature Rat Uterus.Phosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer.Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches Development of subtype-selective oestrogen receptor-based therapeutics.ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq data Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma.Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands.Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells.Unfolding the Role of Stress Response Signaling in Endocrine Resistant Breast Cancers.Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.PKCα and ERβ Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients.Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.Estrogen receptor-beta and breast cancer: translating biology into clinical practice Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer.PES1 promotes breast cancer by differentially regulating ERα and ERβ.ERβ expression and breast cancer risk prediction for women with atypias.A summary of relationships between alternative splicing and breast cancer.Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration Estrogen receptors and human disease: an update.

P2860

Q24315496-BDCE3FF8-91E5-4961-8932-45BB782A1871 Q26773907-F0675DD0-9FDC-4990-A4FA-5E6C0CA8D39E Q28087001-39F82334-E6CF-4801-A808-9A6C934AB500 Q31120324-F49FC1B6-4BA4-42C6-BB28-3180B51930DB Q33677902-AEFEC486-EF36-474B-9C8F-008A6FE105ED Q33718203-087326AD-CC13-41A7-8547-23A7CD347A89 Q33739387-96482554-3BEB-4DF3-9A5B-CCF2672A199A Q33768248-4D817ED7-36DD-499D-80ED-60D928CBD184 Q33866151-75E80FC2-63BB-4C5D-8570-6529046DD787 Q33885342-B0026A19-B042-4F3C-9FA1-E21F39C7C870 Q33903965-7F562818-66CE-4CA6-9224-3D1612812689 Q33989940-E01EF499-3644-454A-83AB-48B49A499807 Q34039793-248A36A5-A4DF-4E06-8826-C59B3D6A1B89 Q34086835-EF1322F4-B3B5-4CC1-B51A-6DA15181B9DA Q34113589-0778539A-65EC-48D3-BB2B-730292963A39 Q34119028-22A19E09-3EE9-4DF5-B974-25A3A38C62BD Q34216817-710B7740-6A1C-4DBA-A87E-C50ECF72872B Q34334131-84D8BD92-8D56-4469-AAF0-6432123CBED7 Q34356351-D9C2D898-7CBA-4BFB-BBE1-2F78544D28A1 Q34663257-868E2E49-527C-48BA-A324-20122CDDA66F Q34991926-C0A791B5-EDFD-4D84-A901-FFA02BDADBB8 Q35000235-E014A785-B7F8-40D1-9103-80D59FE2F3E2 Q35012106-84A984CA-CAE9-4E63-B2CB-D96EF7F4D62C Q35271188-AEC0DC70-D5A5-4205-BB80-0BBCF5041C53 Q35534361-5859D5A1-8EC4-4303-AA13-458EED3590F8 Q35558946-0C78F51F-B36E-43C5-82B3-542C8D1B049D Q35585091-B3A55B21-3C43-4296-9C63-E6871903B1EA Q35763853-1AC78C76-E378-4D54-8A6A-33C7AE177122 Q35809680-0F4A2AD7-C036-4611-BDB0-41D410D94943 Q35821415-37EE39DD-BD82-481D-8416-87FB81F21B1E Q35879517-1C388CEF-5302-47E0-BE13-3183D400BFA0 Q35919319-78BBC1ED-1913-4F2C-B96F-542AEECF1A78 Q35931634-260412C9-2C4D-49B6-A226-9B7E35E5F37F Q35973424-ABE1D85E-7B7D-48E5-962E-198FA652FF7E Q35993074-135041E5-826E-469C-8998-9B9127412CE6 Q36129096-8DB75085-53F9-46C8-85E6-68CE79400E04 Q36248899-23E6C912-4486-49EE-916B-B6F070779832 Q36378283-47E2B2EA-F106-4026-AF41-B1F152A9FB20 Q36413817-46A7F084-1BC4-4A72-A0F7-5BF51BB39589 Q36661810-82B63904-35BA-4069-9703-78A9ACD23C64

P2860

Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.

http://www.wikidata.org/entity/Q38425522

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Clinical importance of estroge ...... th adjuvant tamoxifen therapy.

@en

type

label

Clinical importance of estroge ...... th adjuvant tamoxifen therapy.

@en

prefLabel

Clinical importance of estroge ...... th adjuvant tamoxifen therapy.

@en

P1433

Q38425522-576A1AD3-AA77-46EB-ACAB-3D7E44AD8505

P1476

Q38425522-F3585BEC-4A8A-4864-8ED8-C391342BEE26

P2093

Q38425522-1AE21619-C3CC-47A2-B3B0-4598C528CD88

Q38425522-22626B99-7801-4ACC-B370-587F58A3D2DA

Q38425522-23A5A91A-854D-4DC0-A7B0-A342751C647C

Q38425522-56325111-48BA-42F1-A0E2-D71891E0FB23

Q38425522-8F423993-2458-457F-92B6-39E064F2C224

Q38425522-AAC46CDD-2563-434C-8DBE-DCA64B5214AE

Q38425522-ABBC43A3-4207-4D35-A04A-16DFED7E143C

Q38425522-CAFD18FF-8BBA-497B-A35D-578F7C8672DF

Q38425522-CECB3EB3-F27A-4487-8AF8-B3801BC4A229

Q38425522-CF151A9D-3F58-4701-A3EB-A78CEB282FD1

P304

Q38425522-3FDB2B29-EE70-4762-849F-E150EBE6310F

P31

Q38425522-16D712B7-E46C-4B59-88B0-98E5E7F0A2DB

P356

Q38425522-AEE39CE2-8608-4E82-A66E-7B7F11AEF988

P407

Q38425522-6EF89CFC-D351-40BE-82B9-6D6A2494BD69

P433

Q38425522-4E83C38B-A06D-4880-8617-DD6C47458E3D

P478

Q38425522-529B3A51-CA12-48B2-9C1D-A73FB92F2F8C

P577

Q38425522-BB9BA0C5-55C5-4E35-A096-CC6B272C4D01

P698

Q38425522-F8EF8865-C9A5-4CB5-91A8-041EC9F5BB5B

P356

JCO.2007.14.2968

P1433

Journal of Clinical Oncology

P1476

Clinical importance of estroge ...... th adjuvant tamoxifen therapy.

@en

P2093

Futoshi Akiyama

http://www.w3.org/2001/XMLSchema#string

Goi Sakamoto

http://www.w3.org/2001/XMLSchema#string

Kaiyo Takubo

http://www.w3.org/2001/XMLSchema#string

Mamoun Younes

http://www.w3.org/2001/XMLSchema#string

Masaaki Matsuura

http://www.w3.org/2001/XMLSchema#string

Naoko Honma

http://www.w3.org/2001/XMLSchema#string

Rie Horii

http://www.w3.org/2001/XMLSchema#string

Shigehira Saji

http://www.w3.org/2001/XMLSchema#string

Takuji Iwase

http://www.w3.org/2001/XMLSchema#string

Yoshinori Ito

http://www.w3.org/2001/XMLSchema#string

P304

3727-3734

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2007.14.2968

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18669459

http://www.w3.org/2001/XMLSchema#string